Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-01-22 @ 11:00 AM
Study NCT ID:
NCT03403634
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2018-01-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
Sponsor:
Roswell Park Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
I 52917
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |